Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine, ketamine, and dexamethasone for prevention of respiratory complications after pediatric tonsillectomy
IRCT20210718051928N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lidocaine, ketamine and dexamethasone in respiratory complication (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Prevention of respiratory complications after pediatric tonsillectomy. Started Sep 2021; status: completed.
02
Drugs
lidocaineketaminedexamethasone
03
Conditions
respiratory complication
Beyond the preview
Go deeper on IRCT20210718051928N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210718051928N1.